FDA adviser resigns over approval of new Alzheimer's drug
CNN
A member of an FDA advisory committee said Wednesday he had resigned over the agency's approval of a new Alzheimer's drug.
The FDA approved aducanumab, to be sold under the brand name Aduhelm, this week over the objections of its advisory Peripheral and Central Nervous System Drugs Advisory Committee. Mayo Clinic neurologist Dr. David Knopman told CNN Wednesday he had resigned from the committee in protest.More Related News
Country star Brad Paisley and the Howard Gospel Choir will team up to provide the entertainment at a glitzy, black-tie state dinner at the White House on Thursday as President Joe Biden and first lady Dr. Jill Biden roll out the red carpet for Kenya President William Ruto and first lady Rachel Ruto.